NasdaqGS - Delayed Quote USD
ICON Public Limited Company (ICLR)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 7:49 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
8,306,823.00
8,120,176.00
7,741,386.00
5,480,826.00
2,797,288.00
Cost of Revenue
5,849,310.00
5,719,949.00
5,527,045.00
3,972,612.00
1,979,883.00
Gross Profit
2,457,513.00
2,400,227.00
2,214,341.00
1,508,214.00
817,405.00
Operating Expense
1,314,041.00
1,354,509.00
1,348,266.00
900,317.00
408,575.00
Operating Income
1,143,472.00
1,045,718.00
866,075.00
607,897.00
408,830.00
Net Non Operating Interest Income Expense
-259,521.00
-331,685.00
-227,386.00
-106,458.00
-10,295.00
Other Income Expense
-77,116.00
-89,566.00
-70,838.00
-304,759.00
-17,330.00
Pretax Income
806,835.00
624,467.00
567,851.00
196,680.00
381,205.00
Tax Provision
58,941.00
11,749.00
59,411.00
41,334.00
47,875.00
Earnings from Equity Interest Net of Tax
--
-383.00
-3,136.00
-2,161.00
-366.00
Net Income Common Stockholders
747,894.00
612,335.00
505,304.00
153,185.00
327,809.00
Diluted NI Available to Com Stockholders
747,894.00
612,335.00
505,304.00
153,185.00
327,809.00
Basic EPS
9.06
7.46
6.21
2.28
6.27
Diluted EPS
8.99
7.40
6.13
2.25
6.22
Basic Average Shares
82,638.32
82,101.81
81,532.32
67,110.19
52,859.91
Diluted Average Shares
83,143.92
82,717.64
82,536.83
68,068.31
53,264.75
Total Operating Income as Reported
1,066,356.00
956,152.00
795,237.00
378,529.00
391,500.00
Total Expenses
7,163,351.00
7,074,458.00
6,875,311.00
4,872,929.00
2,388,458.00
Net Income from Continuing & Discontinued Operation
747,894.00
612,335.00
505,304.00
153,185.00
327,809.00
Normalized Income
819,376.51
700,199.25
568,704.01
393,896.27
342,962.55
Interest Income
7,321.00
5,014.00
2,345.00
574.00
2,724.00
Interest Expense
241,162.00
311,019.00
209,189.00
93,809.00
13,406.00
Net Interest Income
-259,521.00
-331,685.00
-227,386.00
-106,458.00
-10,295.00
EBIT
1,047,997.00
935,486.00
777,040.00
290,489.00
394,611.00
EBITDA
1,589,575.00
1,521,436.00
1,346,553.00
605,476.00
460,737.00
Reconciled Cost of Revenue
5,849,310.00
5,719,949.00
5,527,045.00
3,972,612.00
1,979,883.00
Reconciled Depreciation
541,578.00
585,950.00
569,513.00
314,987.00
66,126.00
Net Income from Continuing Operation Net Minority Interest
747,894.00
612,335.00
505,304.00
153,185.00
327,809.00
Total Unusual Items Excluding Goodwill
-77,116.00
-89,566.00
-70,838.00
-304,759.00
-17,330.00
Total Unusual Items
-77,116.00
-89,566.00
-70,838.00
-304,759.00
-17,330.00
Normalized EBITDA
1,666,691.00
1,611,002.00
1,417,391.00
910,235.00
478,067.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-5,633.49
-1,701.75
-7,437.99
-64,047.73
-2,176.45
12/31/2020 - 5/15/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IQV IQVIA Holdings Inc.
192.68
-5.06%
CRL Charles River Laboratories International, Inc.
187.74
-4.65%
MEDP Medpace Holdings, Inc.
310.63
-7.23%
MTD Mettler-Toledo International Inc.
1,179.58
-4.70%
LH Labcorp Holdings Inc.
235.21
-1.25%
WAT Waters Corporation
358.46
-4.85%
RVTY Revvity, Inc.
109.52
-5.63%
A Agilent Technologies, Inc.
127.07
-2.42%
IDXX IDEXX Laboratories, Inc.
420.91
-0.65%
DHR Danaher Corporation
230.50
-3.71%